Trial intelligence / Profile preview

Dexmedetomidine Adjuvant to Epidural Steroid Injection for CLBP

NCT06685081Completed

Sponsor
Menoufia University
Start
Jul 2024
Primary completion
Oct 2024
Modality
Small Molecules
Countries
1
01

Overview

Randomised trial of dexmedetomidine in chronic low back pain (CLBP) (5 arms), sponsored by Menoufia University. Primary endpoint: Proportion of patients reporting at least a 50% reduction in pain at 3 months. Started Jul 2024; status: completed.

02

Drugs

dexmedetomidine
03

Conditions

chronic low back pain (CLBP)

Beyond the preview

Go deeper on NCT06685081.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT06685081.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call